Characteristics of solid parts on the prognosis of lung cancer less than 2 cm in size

J. Wu (Taichung, Taiwan), C. Wu (Taichung, Taiwan), C. Wu (Taoyuan, Taiwan), C. Wang (Taoyuan, Taiwan), T. Yang (Taichung, Taiwan), J. Tseng (Taichung, Taiwan), K. Hsu (Taichung, Taiwan), Y. Huang (Taichung, Taiwan), C. Hsu (Hualien, Taiwan), C. Chuang (Taichung, Taiwan), C. Lin (Taichung, Taiwan), C. Tseng (New Taipei City, Taiwan), K. Chen (Taichung, Taiwan), G. Chang (Taichung, Taiwan)

Source: Virtual Congress 2020 – Screening and early lung cancer
Session: Screening and early lung cancer
Session type: E-poster session
Number: 1613
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Wu (Taichung, Taiwan), C. Wu (Taichung, Taiwan), C. Wu (Taoyuan, Taiwan), C. Wang (Taoyuan, Taiwan), T. Yang (Taichung, Taiwan), J. Tseng (Taichung, Taiwan), K. Hsu (Taichung, Taiwan), Y. Huang (Taichung, Taiwan), C. Hsu (Hualien, Taiwan), C. Chuang (Taichung, Taiwan), C. Lin (Taichung, Taiwan), C. Tseng (New Taipei City, Taiwan), K. Chen (Taichung, Taiwan), G. Chang (Taichung, Taiwan). Characteristics of solid parts on the prognosis of lung cancer less than 2 cm in size. 1613

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm
Source: Eur Respir J 2010; 36: 1355-1361
Year: 2010



Survival of patients with extended small cell lung cancer depending on metastases location
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009

The role of tumor size in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006

Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features
Source: Eur Respir J 2006; 28: Suppl. 50, 335s
Year: 2006

Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018

Surgical treatment of 1a stage non small lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 136s
Year: 2006

Attempting tissue diagnosis in performance status 3 and 4 lung cancer patients may not influence treatment or survival
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013



Survival and prognostic factors of oligometastatic non-small cell lung carcinoma: A single center experience
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017

Characteristics and survival analysis of synchronous oligometastatic non-small cell lung carcinoma.
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020


Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up?
Source: ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020
Year: 2020



Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011


Analysis of the prognosis value of the mitochondrial activity in resected non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010


Giant non small cell lung cancer – diagnosis and treatment
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008


Analysis of survival and characteristics of patients with non-small cell lung carcinoma (NSCLC) stage IV depending on molecular markers
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Unique clinicopathological characteristics and favorable prognosis of young patients with non-small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020

The impact of thrombosis events in excised tumor tissues on the prognosis of non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010


Impact of poor performance status of the treatment of small cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 394s
Year: 2001

Cancer recurrence in surgically treated non small cell lung cancer (NSCLC)
Source: Eur Respir J 2006; 28: Suppl. 50, 755s
Year: 2006